Biogen stock increases as Alzheimer's drug shows promise in early results of study - 1breakingnews.c
1BN-RADIO
2022-09-28
Views 10
Eisai announced results from a global study of nearly 1800 people with early-stage Alzheimer's. The drugmaker said early results showed that its treatment, lecanemab, reduced patient clinical decline by 27% when compared to a placebo or fake drug after ...
VIEW MORE : https://bit.ly/1breakingnews
VIEW MORE : https://bit.ly/1breakingnews
Report form
RELATED VIDEOS
